Menu
Back to Journals » Journal of Hepatocellular Carcinoma » Volume 2
Original Research
Ambovex® as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 10,163 | Dovepress* | 9,695+ | 1,048 | 10,743 | |
| PubMed Central* | 468 | 73 | 541 | ||
| Totals | 10,163 | 1,121 | 11,284 | ||
|
*Since 22 June 2015 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 1 | 0 | 0 | 0 | 1 |
View citations on PubMed Central and Google Scholar